Loading CRTO…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("CRTO","financials")Full statements spill as a table. For one cell: =jivedata("CRTO","Revenue") or =jivedata("CRTO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
CRTO • CIK 0001576427
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax | $1,949,445 | $1,933,289 | $1,944,901 | $1,863,453 |
| Gross Profit | $863,044 | $982,971 | $1,049,380 | $998,842 |
| Operating Income (Loss) | $77,218 | $151,402 | $202,765 | $149,551 |
| Nonoperating Income (Expense) | $-2,490 | $3,095 | $809 | $2,500 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $74,728 | $154,497 | $203,574 | $152,051 |
| Income Tax Expense (Benefit) | $20,084 | $39,784 | $54,195 | $45,272 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $54,644 | $114,713 | $149,379 | $106,779 |
| Net Income (Loss) Attributable to Parent | $53,259 | $111,571 | $144,602 | $104,431 |
| Net Income (Loss) Attributable to Noncontrolling Interest | $1,385 | $3,142 | $4,777 | $2,348 |
| Cost of Goods and Services Sold | $926,839 | $811,806 | $770,284 | $739,436 |
| Other Cost of Operating Revenue | $159,562 | $138,512 | $125,237 | $125,175 |
| Research and Development Expense | $242,289 | $279,341 | $283,303 | $284,572 |
| Selling and Marketing Expense | $406,012 | $376,090 | $394,370 | $380,306 |
| General and Administrative Expense | $137,525 | $176,138 | $168,942 | $184,413 |
| Operating Expenses | $785,826 | $831,569 | $846,615 | $849,291 |
| Weighted Average Number of Shares Outstanding, Basic | 56,170,658 | 54,817,136 | 52,934,526 | 49,461,266 |
| Weighted Average Number of Shares Outstanding, Diluted | 60,231,627 | 58,605,529 | 54,792,540 | 49,384,655 |
| Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | 51,599 | 59,250 | 22,260 | -17,986 |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 348,675 | 236,039 | 2,019,480 | 2,602,016 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 |
|---|
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $54,644 | $114,713 | $149,379 | $106,779 |
| Net Cash Provided by (Used in) Operating Activities | $224,246 | $258,161 | $311,237 | $318,799 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $-5,223 | $-10,159 | $-7,212 | $-7,108 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $-36,943 | $-120,398 | $51,416 | $46,317 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $411,257 | $290,943 | $342,359 | $376,490 |
| Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities | $103,369 | $192,118 | $175,203 | $170,471 |
| Payments to Acquire Productive Assets | — | $78,112 | $102,739 | $141,485 |
| Proceeds from Sale of Productive Assets | — | $1,476 | $2,013 | $2,707 |
| Loss Contingency Accrual, Payments | $43,334 | $0 | $0 | $0 |
| Proceeds from Divestiture of Businesses | $8,847 | $0 | $0 | $0 |
| Share-based Payment Arrangement, Noncash Expense | $97,185 | $106,613 | $57,848 | $50,382 |
| Payments to Acquire Businesses, Net of Cash Acquired | $6,825 | $527 | $0 | $0 |
| Payments to Acquire Marketable Securities | — | — | $28,436 | $28,357 |
| Proceeds from Sale and Maturity of Marketable Securities | — | $5,950 | $28,029 | $12,056 |
| Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | $2,344 | $1,007 | $0 | $0 |
| Net Cash Provided by (Used in) Investing Activities | $-108,712 | $-97,901 | $-101,133 | $-155,079 |
| Deferred Income Tax Expense (Benefit) | $-23,588 | $-26,040 | $-7,533 | $-14,668 |
| Increase (Decrease) in Income Taxes | $4,424 | $19,389 | $-21,992 | $596 |
| Other Noncash Income (Expense) | $-2,811 | $280 | $-5,347 | $-1,004 |
| Increase (Decrease) in Operating Capital | $-66,233 | $48,670 | $13,345 | $-41,549 |
| Proceeds from Stock Options Exercised | — | — | $1,897 | $0 |
| Increase (Decrease) in Accounts Receivable | $56,344 | $28,516 | $-245,977 | $-214,879 |
| Payments for Repurchase of Common Stock | $125,489 | $224,595 | $152,064 | $108,890 |
| Increase (Decrease) in Accounts Payable, Trade | $87,937 | $-17,160 | $-265,395 | $-163,105 |
| Payment for Contingent Consideration Liability, Financing Activities | $22,025 | $51,983 | $0 | $0 |
| Increase (Decrease) in Other Current Assets | $8,479 | $-10,142 | $-13,665 | $14,112 |
| Proceeds from (Payments for) Other Financing Activities | $-1,920 | $1,529 | $-1,309 | $-1,405 |
| Increase (Decrease) in Other Current Liabilities | $43,815 | $-11,314 | $-7,505 | $3,022 |
| Net Cash Provided by (Used in) Financing Activities | $-147,254 | $-270,499 | $-151,476 | $-110,295 |
| Income Taxes Paid, Net | $40,127 | $40,705 | $64,930 | $35,508 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $1,539 | $1,360 | $1,584 | $1,990 |
| Capital Expenditures Incurred but Not yet Paid | — | $1,758 | $18,126 | $24,222 |